Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

ChemoMetec

520.00 DKK-0.95 %25/9 11:23
Less than 1K followers

CHEMM

NASDAQ Copenhagen

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor views
Compare
-0.95 %
+6.78 %
+41.92 %
+119.59 %
-24.36 %
-18.56 %
+54.39 %
-52.38 %
+2,263.64 %

ChemoMetec specializes in the design, development, and production of patented instruments for cell counting and cell analysis. The company cooperates and statutes agreements with actors such as research institutes, universities, food companies, hospitals, and specialist clinics. Customers are found in a global market. The company was founded in 1997 and is headquartered in Alleröd, Denmark.

Read more
Market cap
9.05B DKK
Turnover
3.46M DKK
Revenue
511.06M
EBIT %
49.11 %
P/E
44.83
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
8/10
2026

General meeting '26

3/2
2027

Interim report Q2'27

9/9
2027

Annual report '27

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release2026-09-16 14:37

Major shareholder announcement - BlackRock, Inc.

ChemoMetec
Regulatory press release2026-09-16 14:22

Notice of Annual General Meeting 2026

ChemoMetec
Regulatory press release2026-09-10 20:39

Positioning ChemoMetec for future growth

ChemoMetec

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release2026-09-10 20:20

Guidance for the 2026/27 financial year

ChemoMetec
Regulatory press release2026-08-10 12:32

ChemoMetec enters collaboration agreement with Roche Diagnostics

ChemoMetec
Press release2026-08-07 15:04

ChemoMetec A/S invites to conference call on September 11, 2026 at 3:00 p.m. CEST on its upcoming 2025/26 Annual Report

ChemoMetec
Regulatory press release2026-08-01 10:24

Appointment of new CFO

ChemoMetec
Regulatory press release2026-05-15 11:43

Initiation of buy-back programme

ChemoMetec
Regulatory press release2026-05-06 18:52

Growth in revenue and operating profit

ChemoMetec
Regulatory press release2026-05-04 15:17

Adjustment of accounting estimates contributes to an upgrade of revenue and operating profit guidance

ChemoMetec
Regulatory press release2026-03-27 10:06

Notification of managers’ transactions

ChemoMetec
Regulatory press release2026-03-27 09:53

Notification of managers’ transactions

ChemoMetec
Regulatory press release2026-03-26 11:40

Notification of managers’ transactions

ChemoMetec
Regulatory press release2026-03-24 16:08

Adjustment of guidance for 2025/26

ChemoMetec
Regulatory press release2026-03-02 10:50

Notification of managers’ transactions

ChemoMetec
Regulatory press release2026-02-09 10:28

Notification of managers’ transactions

ChemoMetec
Regulatory press release2026-02-04 18:16

ChemoMetec enters Letter of Intent with Roche Diagnostics

ChemoMetec
Regulatory press release2026-02-04 18:09

Interim report 2025/26 - Organic growth despite challenges in the North American market

ChemoMetec
Regulatory press release2025-11-07 13:27

Notification of managers’ transactions

ChemoMetec
Regulatory press release2025-11-07 13:18

Notification of managers’ transactions

ChemoMetec